---
figid: PMC7764608__diagnostics-10-01076-g005
figlink: pmc/articles/PMC7764608/figure/diagnostics-10-01076-f005/
number: Figure 5
caption: 'NF-ĸB signaling pathway. In PCNSL, activation of NF-ĸB signaling pathway
  can be mediated through the gain of 18q21.33-q23, activating the mutation of CARD11
  and stimulation of the B-cell receptor (BCR), tumor necrosis factor (TNF), or toll-like
  receptor (TLR) pathway. MYD88 mutations, which are frequently seen in PCNSL, lead
  to spontaneous assembly of a protein complex containing IRAK1 and IRAK4, ultimately
  resulting in NF-ĸB signaling pathway activation, Janus kinase (JAK) activation of
  STAT3 pathway, and the secretion of IL-6, IL-10, and interferon-β. TNF-R: TNF receptor,
  MYD88: Myeloid differentiation primary response gene 88, CARD11: Caspase recruitment
  domain family member 11, IRAK1/4: Interleukin 1 receptor-associated kinase 1/4,
  TRAF6: Tumor necrosis factor receptor (TNFR)-associated factor 6, BCR: B-cell receptor,
  SyK: Spleen tyrosine kinase, BTK: Bruton’s tyrosine kinase, PKC-β: Protein kinase
  C β type, MALT1: Mucosa-associated lymphoid tissue lymphoma 1, Bcl-10: B-cell lymphoma/leukemia
  10, JAK1/2: Janus kinase 1/2, STAT3/6: Signal transducer and activator of transcription
  3/6, IL-4/10: Interleukin 4/10.'
pmcid: PMC7764608
papertitle: 'Primary Central Nervous System Lymphomas: A Diagnostic Overview of Key
  Histomorphologic, Immunophenotypic, and Genetic Features.'
reftext: Marietya I. S. Lauw, et al. Diagnostics (Basel). 2020 Dec;10(12):1076.
pmc_ranked_result_index: '15428'
pathway_score: 0.9727979
filename: diagnostics-10-01076-g005.jpg
figtitle: NF-ĸB signaling pathway
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7764608__diagnostics-10-01076-g005.html
  '@type': Dataset
  description: 'NF-ĸB signaling pathway. In PCNSL, activation of NF-ĸB signaling pathway
    can be mediated through the gain of 18q21.33-q23, activating the mutation of CARD11
    and stimulation of the B-cell receptor (BCR), tumor necrosis factor (TNF), or
    toll-like receptor (TLR) pathway. MYD88 mutations, which are frequently seen in
    PCNSL, lead to spontaneous assembly of a protein complex containing IRAK1 and
    IRAK4, ultimately resulting in NF-ĸB signaling pathway activation, Janus kinase
    (JAK) activation of STAT3 pathway, and the secretion of IL-6, IL-10, and interferon-β.
    TNF-R: TNF receptor, MYD88: Myeloid differentiation primary response gene 88,
    CARD11: Caspase recruitment domain family member 11, IRAK1/4: Interleukin 1 receptor-associated
    kinase 1/4, TRAF6: Tumor necrosis factor receptor (TNFR)-associated factor 6,
    BCR: B-cell receptor, SyK: Spleen tyrosine kinase, BTK: Bruton’s tyrosine kinase,
    PKC-β: Protein kinase C β type, MALT1: Mucosa-associated lymphoid tissue lymphoma
    1, Bcl-10: B-cell lymphoma/leukemia 10, JAK1/2: Janus kinase 1/2, STAT3/6: Signal
    transducer and activator of transcription 3/6, IL-4/10: Interleukin 4/10.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4
  - IL10
  - TNFRSF1A
  - BCR
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - JAK1
  - JAK2
  - MYD88
  - SYK
  - BTK
  - STAT6
  - STAT3
  - IRAK1
  - PRKCB
  - IRAK4
  - CARD11
  - PIM1
  - MALT1
  - PIM2
  - TRAF6
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - BCL2
  - RGS13
  - MYC
  - CD44
  - CD79A
  - CD79B
genes:
- word: IL-4
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: TNF-R
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: (JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: (JAK2)
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MYD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: ВТК
  symbol: BTK
  source: hgnc_symbol
  hgnc_symbol: BTK
  entrez: '695'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: IRAK1
  symbol: IRAK1
  source: hgnc_symbol
  hgnc_symbol: IRAK1
  entrez: '3654'
- word: PKC-B
  symbol: PKCB
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: CARD11
  symbol: CARD11
  source: hgnc_symbol
  hgnc_symbol: CARD11
  entrez: '84433'
- word: PIM1
  symbol: PIM1
  source: hgnc_symbol
  hgnc_symbol: PIM1
  entrez: '5292'
- word: MALT1
  symbol: MALT1
  source: hgnc_symbol
  hgnc_symbol: MALT1
  entrez: '10892'
- word: PIM2
  symbol: PIM2
  source: hgnc_symbol
  hgnc_symbol: PIM2
  entrez: '11040'
- word: TRAF6
  symbol: TRAF6
  source: hgnc_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: MYC,CD44,RGS13,CyclinD1/2,BCL2,BCL2RA1
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: MYC,CD44,RGS13,CyclinD1/2,BCL2,BCL2RA1
  symbol: RGS13
  source: hgnc_symbol
  hgnc_symbol: RGS13
  entrez: '6003'
- word: MYC,CD44,RGS13,CyclinD1/2,BCL2,BCL2RA1
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MYC,CD44,RGS13,CyclinD1/2,BCL2,BCL2RA1
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: BCL2,
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: CD44,
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: RGS13,
  symbol: RGS13
  source: hgnc_symbol
  hgnc_symbol: RGS13
  entrez: '6003'
- word: MYC,
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: CD79A
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
- word: CD79B
  symbol: CD79B
  source: hgnc_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: CD79B
  symbol: CD79B
  source: hgnc_symbol
  hgnc_symbol: CD79B
  entrez: '974'
- word: CD79A
  symbol: CD79A
  source: hgnc_symbol
  hgnc_symbol: CD79A
  entrez: '973'
chemicals: []
diseases: []
---
